Reaction
Catheter Site Rash reporting signals
As of the last recalculation, Catheter Site Rash appears in 445 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 1,099.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 182 | 1,099.6 | 1,115.2 |
| Macitentan | 143 | 141.9 | 142.2 |
| Sildenafil | 76 | 73.8 | 73.9 |
| Tadalafil | 117 | 73.8 | 73.9 |
| Treprostinil | 129 | 67.3 | 67.4 |
| Riociguat | 37 | 57.8 | 57.9 |
| Sildenafil Citrate | 111 | 54.0 | 54.1 |
| Sildenafil Powder, | 37 | 52.9 | 53.0 |
| 0Xygen | 47 | 49.8 | 49.8 |
| Oxygen | 47 | 49.8 | 49.8 |
| Ambrisentan | 90 | 42.0 | 42.0 |
| Selexipag | 21 | 39.9 | 39.9 |
| Blinatumomab | 5 | 22.7 | 22.7 |
| Bosentan | 22 | 21.4 | 21.4 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 6 | 9.1 | 9.1 |